(Q43025556)

12 November 2017

Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia (English)

1 reference

12 November 2017

1 reference

1 reference

10

Jean-Christophe Rozé

0 references

author name string

Marion Strullu

1

1 reference

12 November 2017

Nadège Corradini

2

1 reference

12 November 2017

Marie Audrain

3

1 reference

12 November 2017

Jean-Luc Orsonneau

4

1 reference

12 November 2017

Daniel Bouige

5

1 reference

12 November 2017

Patrick Thomare

6

1 reference

12 November 2017

Claudine Vermot-Desroches

7

1 reference

12 November 2017

Adeline Mansuy

8

1 reference

12 November 2017

Arnaud Legrand

9

1 reference

12 November 2017

Jean-Christophe Rozé

10

1 reference

12 November 2017

Mohamad Mohty

11

1 reference

12 November 2017

Françoise Méchinaud

12

1 reference

12 November 2017

language of work or name

1 reference

1 August 2010

1 reference

12 November 2017

1 reference

12 November 2017

51

1 reference

12 November 2017

8

1 reference

12 November 2017

1464-1472

1 reference

Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia

12 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Toxicity of L-asparaginase in children with advanced leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Lack of asparagine depletion in the cerebrospinal fluid after one intravenous dose of PEG-asparaginase: a window study at initial diagnosis of childhood ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.494316

10.3109/10428194.2010.494316

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference